These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33264531)

  • 1. Pharmacology Focus: Guideline Recommendation Changes for Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus Aureus Infections: Clinical Implications and Challenges.
    Laible B
    S D Med; 2020 Oct; 73(10):493-494. PubMed ID: 33264531
    [No Abstract]   [Full Text] [Related]  

  • 2. Vancomycin in the treatment of serious methicillin-resistant Staphylococcus aureus infections: time to move on to alternative agents?
    Laible BR
    S D Med; 2011 Dec; 64(12):465, 467. PubMed ID: 22312751
    [No Abstract]   [Full Text] [Related]  

  • 3. Vancomycin in combination with other antibiotics for the treatment of serious methicillin-resistant Staphylococcus aureus infections.
    Deresinski S
    Clin Infect Dis; 2009 Oct; 49(7):1072-9. PubMed ID: 19725789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methicillin-resistant Staphylococcus aureus and vancomycin: minimum inhibitory concentration matters.
    Deresinski S
    Clin Infect Dis; 2012 Mar; 54(6):772-4. PubMed ID: 22302375
    [No Abstract]   [Full Text] [Related]  

  • 5. Should laboratories test methicillin-resistant Staphylococcus aureus for elevated vancomycin minimum inhibitory concentrations by Etest as a driver of treatment changes?
    Humphries RM; Hindler JA
    Clin Infect Dis; 2012 Aug; 55(4):612-3. PubMed ID: 22573854
    [No Abstract]   [Full Text] [Related]  

  • 6. Best alternative to vancomycin for serious methicillin-resistant Staphylococcus aureus infections: let's just say it.
    Bush LM
    Clin Infect Dis; 2011 Nov; 53(9):965-6. PubMed ID: 21880584
    [No Abstract]   [Full Text] [Related]  

  • 7. [Current view of vancomycin in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections].
    Martínková J
    Klin Mikrobiol Infekc Lek; 2015 Mar; 21(1):16-23. PubMed ID: 26098489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emergence of vancomycin-resistant Staphylococcus aureus in an intensive care unit in Kerman, Iran.
    Fasihi Y; Saffari F; Mansouri S; Kalantar-Neyestanaki D
    Wien Med Wochenschr; 2018 Mar; 168(3-4):85-88. PubMed ID: 28424995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vancomycin minimum inhibitory concentrations and outcome in patients with severe Staphylococcus aureus infection.
    Gould IM
    J Infect Dis; 2012 Mar; 205(5):864-5; author reply 865-6. PubMed ID: 22238463
    [No Abstract]   [Full Text] [Related]  

  • 10. Heaping the Pelion of Vancomycin on the Ossa of Methicillin-resistant Staphylococcus aureus: Back to Basics in Clinical Care and Guidelines.
    Wright WF; Jorgensen SCJ; Spellberg B
    Clin Infect Dis; 2021 May; 72(10):e682-e684. PubMed ID: 32901250
    [No Abstract]   [Full Text] [Related]  

  • 11. Vancomycin for treatment of infections with methicillin-resistant Staphylococcus aureus: are there alternatives?
    Milatovic D
    Eur J Clin Microbiol; 1986 Dec; 5(6):689-92. PubMed ID: 3643105
    [No Abstract]   [Full Text] [Related]  

  • 12. Vancomycin, unbeatable for methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia? Really?
    Luna CM; Bruno D; Aruj P
    Crit Care Med; 2010 Sep; 38(9):1910-2. PubMed ID: 20724890
    [No Abstract]   [Full Text] [Related]  

  • 13. Should Therapeutic Drug Monitoring Based on the Vancomycin Area Under the Concentration-Time Curve Be Standard for Serious Methicillin-Resistant Staphylococcus aureus Infections?-No.
    Jorgensen SCJ; Spellberg B; Shorr AF; Wright WF
    Clin Infect Dis; 2021 May; 72(9):1502-1506. PubMed ID: 33740050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternatives to vancomycin in treating methicillin-resistant Staphylococcus aureus infections.
    Rahman M
    J Antimicrob Chemother; 1998 Mar; 41(3):325-8. PubMed ID: 9578158
    [No Abstract]   [Full Text] [Related]  

  • 15. Increasing levels of minimum inhibitory concentration vancomycin in methicillin resistant Staphylococcus aureus alarming bell for vancomycin abusers?
    Veer P; Chande C; Chavan S; Wabale V; Chopdekar K; Bade J; Joshi A
    Indian J Med Microbiol; 2010; 28(4):413-4. PubMed ID: 20966589
    [No Abstract]   [Full Text] [Related]  

  • 16. [Impact of vancomycin minimum inhibitory concentration or inadequate therapeutic management in the clinical outcome failure due to methicillin-resistant Staphylococcus aureus?].
    González-Abad MJ; Alonso Sanz M
    An Pediatr (Barc); 2015 May; 82(5):373-4. PubMed ID: 25205179
    [No Abstract]   [Full Text] [Related]  

  • 17. Alternative agents for the treatment of invasive infections due to methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to vancomycin.
    Tattevin P; Arvieux C; Michelet C
    Arch Intern Med; 2007 Jun; 167(11):1206; author reply 1208-9. PubMed ID: 17563033
    [No Abstract]   [Full Text] [Related]  

  • 18. Vancomycin treatment failure in a vancomycin susceptible methicillin-resistant Staphylococcus aureus (MRSA) infected patient.
    Norazah A; Salbiah N; Nurizzat M; Santhana R
    Med J Malaysia; 2009 Jun; 64(2):166-7. PubMed ID: 20058580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Firvanq--vancomycin oral solution.
    Med Lett Drugs Ther; 2018 Jul; 60(1551):122. PubMed ID: 30036349
    [No Abstract]   [Full Text] [Related]  

  • 20. Audit of the management of Staphylococcus aureus bloodstream infection: gaps to be plugged.
    Barry A; McNicholas S; Smyth E; Humphreys H; Fitzpatrick F
    J Hosp Infect; 2010 Nov; 76(3):272-3. PubMed ID: 20435374
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.